Peripheral hepatic sinusoidal obstruction syndrome due to oxaliplatin-based chemotherapy.

Hepatic sinusoidal obstruction syndrome during oxaliplatin-based chemotherapy has been shown to be associated with severe steatohepatitis. Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging may identify various features of hepatic sinusoidal obstruction syndrome, even when the lesion cannot be differentiated from sinusoidal obstruction syndrome by other imaging tools.